Video Consultation for Parents with a Child Newly Diagnosed with Type 1 Diabetes: A Qualitative Study.
Journal
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
ISSN: 1439-3646
Titre abrégé: Exp Clin Endocrinol Diabetes
Pays: Germany
ID NLM: 9505926
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
pubmed:
21
10
2021
medline:
16
8
2022
entrez:
20
10
2021
Statut:
ppublish
Résumé
With the exception of the coronavirus pandemic, video consultations have not been a part of the standard care for children with diabetes in Germany. The "Virtual Diabetes Outpatient Clinic for Children and Adolescents 2.0" (VIDIKI 2.0) study investigated the effect of monthly and supplementary video consultations on standard care over one year. The qualitative substudy investigated the experiences of families with a child newly diagnosed with type 1 diabetes mellitus (T1DM) who received at least four weekly supplementary video consultations. Guideline-based qualitative interviews were conducted with seven families with children under the age of eight and T1DM onset shortly before study entry. The answers were analyzed using a qualitative content analysis approach, particularly inductive category formation. Families of patients with T1DM onset have questions, almost daily, concerning various aspects of insulin therapy. The offer of high-frequency video consultations can reduce the number of trips to the diabetes team, facilitate the organization of daily life and increase the sense of security. Video consultations as a supplementary offer of health care, especially after diabetes onset, were considered very helpful by the affected families. High-frequency video consultations may provide a tool to overcome existing deficiencies in specialized diabetes care.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
519-524Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
SVS reports being a consultant for Abbott, Dexcom, Lilly, NovoNordisk, and Medtronic and has received lecture fees from Abbott, Berlin-Chemie, Hexal, Infectopharm, Lilly, NovoNordisk, Merck, Medtronic, and Sanofi, with no potential conflicts of interest relevant to this article. All other authors declare no potential conflicts of interest relevant to this manuscript.